SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-19-109795
Filing Date
2019-04-18
Accepted
2019-04-18 06:15:34
Documents
4
Period of Report
2019-05-31
Effectiveness Date
2019-04-18

Document Format Files

Seq Description Document Type Size
1 DEF 14A d684860ddef14a.htm DEF 14A 525177
2 GRAPHIC g684860g56e86.jpg GRAPHIC 36045
3 GRAPHIC g684860g60k19.jpg GRAPHIC 120701
4 GRAPHIC g684860g96d70.jpg GRAPHIC 127362
  Complete submission text file 0001193125-19-109795.txt   917619
Mailing Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139 617-229-5872
Epizyme, Inc. (Filer) CIK: 0001571498 (see all company filings)

IRS No.: 261349956 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35945 | Film No.: 19754462
SIC: 2834 Pharmaceutical Preparations